The study used evidence gathered from patient experiences rather than a controlled trial, Novo said.

Eli Lilly's retatrutide is still in clinical trials. But gym bros are already using a version of the weight-loss drug, amid a growing DIY culture in fitness circles.

We’re counting down the days until the Dallas Cowboys battle the Philadelphia Eagles in the season opener of the 2025 NFL season. To pass the time and mark the days, we are running through 100 Days of ...

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Novo Nordisk (NVO) stock in focus as its obesity drug Wegovy outperforms Eli Lilly's (LLY) rival Zepbound in reducing serious ...

Eli Lilly's orforglipron outshines Novo Nordisk's oral semaglutide with efficacy & scalability, promising growth in the ...

The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst ...

Eli Lilly has temporarily paused shipments of its weight-loss drug Mounjaro in the UK, ahead of a new price hike for the ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight ...

Eli Lilly announced this week that its new weight-loss pill, orforglipron, cleared its latest Phase 3 trial, bringing it closer to potential Food and Drug Administration (FDA) approval. Compared with ...

Geena Rocero's sci-fi thriller 'Dolls' drops first trailer with Lilly Wachowski as EP, premiering at Oscar-qualifying Out on ...